 |
BioWorld-Insight-2003-03-17
Stock Winners and Losers For The Week
Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: February 2003
No Abstract
FDA's 'Two-Animal' Rule Becomes Part Of Vical's Anthrax Vaccine Bid
What better way to turn around a company than on the government's dime?